Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VALN · against 454 other Healthcare companies listed in US-listed
Ranked #405 of 455 · scores higher than 11% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 10–19, including VALN · Click a bar to see the companies
Mainly because of its 3-year revenue growth, earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | VALN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 3.0% | 11.0% | 28% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | -21.5% | 11.0% | 8% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 401 | 810M USD | 14 | 69 | |
| 401 | 2.8B USD | 14 | 22 | |
| 401 | 171.0B USD | 14 | 45 | |
| 405 | 549M USD | 13 | 30 | |
| 405 | 522M USD | 13 | 12 | |
| 407 | 3.1B USD | 12 | 27 | |
| 408 | 1.2B USD | 11 | 6 | |
| 408 | 157M USD | 11 | ||
| 410 | 158M USD | 10 | 14 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score